CN Patent
CN110913931B — 带有缩回功能的化学驱动的自动注射器
Assigned to Eli Lilly and Co · Expires 2022-06-03 · 4y expired
What this patent protects
公开了使用产生气体的化学反应进行治疗流体的胃肠外递送的自动注射装置(即,自动注射器)和方法。所产生的气体可将自动注射器置于以下构型:穿刺构型,用以用针刺穿患者的皮肤;注射构型,用以将治疗流体递送穿过针并送入穿刺部位中;和/或缩回构型,用以将针从穿刺部位撤回。
USPTO Abstract
公开了使用产生气体的化学反应进行治疗流体的胃肠外递送的自动注射装置(即,自动注射器)和方法。所产生的气体可将自动注射器置于以下构型:穿刺构型,用以用针刺穿患者的皮肤;注射构型,用以将治疗流体递送穿过针并送入穿刺部位中;和/或缩回构型,用以将针从穿刺部位撤回。
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.